U.S. House to vote on $25 billion postal infusion, mail-in ballot safeguards

Disclaimer: Information provided by this website is for research purposes only and should not be considered as personalized financial advice. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company. BulletsDaily, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation.